Literature DB >> 9503017

The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus.

A B Csóka1, G I Frost, H H Heng, S W Scherer, G Mohapatra, R Stern, T B Csóka.   

Abstract

We recently cloned and expressed the major hyaluronidase activity from human plasma, HYAL1, and found that the protein is 40% identical to the testicular hyaluronidase, PH-20. The HYAL1 mRNA sequence was used in a homology search of the mouse database of expressed sequence tags (dbEST). Two ESTs were obtained and, in combination with 5'RACE-PCR, were used to clone the mouse HYAL1 ortholog (Hyal1). Hyal1 codes for a protein of 462 amino acids that is 73% identical to the human sequence. Hyal1 stably expressed in human embryonic kidney cells resulted in a 20,000-fold increase of hyaluronidase activity. Sequence-tagged sites derived from the HYAL1 gene from both species were used to isolate P1 genomic clones that were used as probes for fluorescence in situ hybridization. The human gene was localized to chromosome 3p21 and the mouse gene to a syntenic region on chromosome 9F1-F2. In mouse, serum hyaluronidase polymorphism has previously been mapped by an interspecific backcross to 60 cM from the centromere of chromosome 9, which corresponds to a cytogenetic location of 9F1-F2. The mouse Hyal1 gene is therefore very likely to be responsible for the hyaluronidase polymorphism linked to this locus. We also present evidence that human HYAL1 is identical to an uncharacterized gene positionally cloned by others from chromosome 3p21.3 that is homozygously deleted in several small-cell lung carcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503017     DOI: 10.1006/geno.1997.5158

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Reverse hyaluronan substrate gel zymography procedure for the detection of hyaluronidase inhibitors.

Authors:  K Mio; R Stern
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

2.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2.

Authors:  J A Sloane; C Batt; Y Ma; Z M Harris; B Trapp; T Vartanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

3.  Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.

Authors:  Sanaa Eissa; Hanan Shehata; Amal Mansour; Mohamed Esmat; Omar El-Ahmady
Journal:  Med Oncol       Date:  2012-07-04       Impact factor: 3.064

4.  Synovium, synergy and serendipity.

Authors:  Gregory M Pastores
Journal:  J Inherit Metab Dis       Date:  2011-10       Impact factor: 4.982

5.  Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.

Authors:  B Triggs-Raine; T J Salo; H Zhang; B A Wicklow; M R Natowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 6.  Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism.

Authors:  Barbara Triggs-Raine; Marvin R Natowicz
Journal:  World J Biol Chem       Date:  2015-08-26

Review 7.  Hyaluronan: a simple polysaccharide with diverse biological functions.

Authors:  Kevin T Dicker; Lisa A Gurski; Swati Pradhan-Bhatt; Robert L Witt; Mary C Farach-Carson; Xinqiao Jia
Journal:  Acta Biomater       Date:  2013-12-18       Impact factor: 8.947

Review 8.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 9.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

10.  Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases.

Authors:  Edith S A Hofinger; Julia Hoechstetter; Martin Oettl; Günther Bernhardt; Armin Buschauer
Journal:  Glycoconj J       Date:  2007-07-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.